Immix Biopharma, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:IMMX) | MetaTrader

展开完整图表完整图表

新闻

Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High?

Citizens首次覆盖Immix Biopharma股票,给予跑赢大盘评级

Citizens initiates Immix Biopharma stock coverage with outperform rating

Immix Biopharma股价上涨，FDA授予突破性疗法地位

FDA授予ImmixBio淀粉样变性药物突破性疗法地位

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Immix Biopharma首席财务官Gabriel Morris购入价值5千美元股票

Immix Biopharma首席执行官Ilya Rachman购入价值$4,975股票

Immix Biopharma CFO Gabriel Morris buys $5k in shares